InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Nichols David Wayne, Chief Technology Officer. Director active across 1 company, notably Magenta Therapeutics, Inc.. Aggregated, 4 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €65k. History available since 14 September 2021. The latest transaction was disclosed on 16 September 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
5,694 shares@ US$6.7350.0% of flowCommon StockSEC:0000899243-21-036595:0
5,694 shares@ US$6.7350.0% of flowCommon StockSEC:0000899243-21-036595
20,000 shares0Common StockSEC:0000899243-21-036333:0
20,000 shares0Common StockSEC:0000899243-21-036333
4 of 4 declarations
About Nichols David Wayne
David Wayne Nichols is the Chief Technical Officer at Magenta Therapeutics, Inc. He is responsible for technical direction and product innovation. David leverages his expertise to guide technological development and ensure the quality of the solutions offered by the company.
